Eurobio Scientific and Vivo Medical Group enter into exclusive negotiations for the acquisition of two companies in the United Kingdom (addendum)


You May Also Like

G1 Therapeutics Announces Pricing of Initial Public Offering

RESEARCH TRIANGLE PARK, N.C., May 16, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a ...

Beyond Celiac Webcast Welcomes a Global Audience

October Research Symposium to Present the Latest on the Microbiome, Immune System and Celiac ...